Earnings ·
Nuo Therapeutics reported second quarter 2026 total revenues of approximately $1.77 million, a year-over-year increase…
AURXNuo Therapeutics, Inc.
Nuo Therapeutics reported second quarter 2026 total revenues of approximately $1.77 million, a year-over-year increase exceeding 150%, with product sales reaching $1.69 million. The company posted a net loss of $277,601, an improvement from the prior year's loss of $649,689. Nuo also disclosed an amended loan agreement providing interim funding of $675,000, with $325,000 remaining available under total commitments of $2 million. The firm operates in the medical device industry, developing and marketing regenerative therapies for chronic wound care.